According to results of a Mayo Clinic study published June 4 in JAMA, which analyzed results from more than 400 randomized clinical trials, less than one out of five included patient-important outcomes as primary endpoints. Victor Montori, M.D., a Mayo Clinic endocrinologist and the lead author of the study conducted at Mayo’s Knowledge and Encounter Research Unit , explains why failure to include outcomes patients would consider important is a significant shortcoming.
In the second clip, Dr. Montori further elaborates and describes the effect he hopes the Mayo Clinic study has in influencing the direction of clinical trials for diabetes treatments:
Update: This story was covered in the Rochester Post-Bulletin, Medical News Today (UK), and MedPage Today, as well as the Wall Street Journal Health Blog.
